Century Therapeutics, Inc. (IPSC) Tops Q1 EPS by 96c
Tweet
Share
E-mailGet Alerts IPSC Hot Sheet
Join SI Premium – FREE
Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q1 EPS of $0.89, $0.96 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $109.16 million versus the consensus estimate of $19.94 million.
For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
